Downstream effects of polypathology on neurodegeneration of medial temporal lobe subregions

Acta Neuropathol Commun. 2021 Jul 21;9(1):128. doi: 10.1186/s40478-021-01225-3.

Abstract

The medial temporal lobe (MTL) is a nidus for neurodegenerative pathologies and therefore an important region in which to study polypathology. We investigated associations between neurodegenerative pathologies and the thickness of different MTL subregions measured using high-resolution post-mortem MRI. Tau, TAR DNA-binding protein 43 (TDP-43), amyloid-β and α-synuclein pathology were rated on a scale of 0 (absent)-3 (severe) in the hippocampus and entorhinal cortex (ERC) of 58 individuals with and without neurodegenerative diseases (median age 75.0 years, 60.3% male). Thickness measurements in ERC, Brodmann Area (BA) 35 and 36, parahippocampal cortex, subiculum, cornu ammonis (CA)1 and the stratum radiatum lacunosum moleculare (SRLM) were derived from 0.2 × 0.2 × 0.2 mm3 post-mortem MRI scans of excised MTL specimens from the contralateral hemisphere using a semi-automated approach. Spearman's rank correlations were performed between neurodegenerative pathologies and thickness, correcting for age, sex and hemisphere, including all four proteinopathies in the model. We found significant associations of (1) TDP-43 with thickness in all subregions (r = - 0.27 to r = - 0.46), and (2) tau with BA35 (r = - 0.31) and SRLM thickness (r = - 0.33). In amyloid-β and TDP-43 negative cases, we found strong significant associations of tau with ERC (r = - 0.40), BA35 (r = - 0.55), subiculum (r = - 0.42) and CA1 thickness (r = - 0.47). This unique dataset shows widespread MTL atrophy in relation to TDP-43 pathology and atrophy in regions affected early in Braak stageing and tau pathology. Moreover, the strong association of tau with thickness in early Braak regions in the absence of amyloid-β suggests a role of Primary Age-Related Tauopathy in neurodegeneration.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / diagnostic imaging
  • Alzheimer Disease / metabolism
  • Alzheimer Disease / pathology
  • Amyloid beta-Peptides / metabolism
  • Brain Cortical Thickness
  • CA1 Region, Hippocampal / diagnostic imaging
  • CA1 Region, Hippocampal / metabolism
  • CA1 Region, Hippocampal / pathology
  • Case-Control Studies
  • DNA-Binding Proteins / metabolism
  • Entorhinal Cortex / diagnostic imaging*
  • Entorhinal Cortex / metabolism
  • Entorhinal Cortex / pathology
  • Female
  • Frontotemporal Lobar Degeneration / diagnostic imaging
  • Frontotemporal Lobar Degeneration / metabolism
  • Frontotemporal Lobar Degeneration / pathology
  • Hippocampus / diagnostic imaging*
  • Hippocampus / metabolism
  • Hippocampus / pathology
  • Humans
  • Lewy Body Disease / diagnostic imaging
  • Lewy Body Disease / metabolism
  • Lewy Body Disease / pathology
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Neurodegenerative Diseases / diagnostic imaging*
  • Neurodegenerative Diseases / metabolism
  • Neurodegenerative Diseases / pathology
  • Neurofibrillary Tangles / pathology
  • Parahippocampal Gyrus / diagnostic imaging
  • Parahippocampal Gyrus / metabolism
  • Parahippocampal Gyrus / pathology
  • Pick Disease of the Brain / diagnostic imaging
  • Pick Disease of the Brain / metabolism
  • Pick Disease of the Brain / pathology
  • Plaque, Amyloid / pathology
  • Supranuclear Palsy, Progressive / diagnostic imaging
  • Supranuclear Palsy, Progressive / metabolism
  • Supranuclear Palsy, Progressive / pathology
  • Temporal Lobe / diagnostic imaging*
  • Temporal Lobe / metabolism
  • Temporal Lobe / pathology
  • alpha-Synuclein / metabolism
  • tau Proteins / metabolism

Substances

  • Amyloid beta-Peptides
  • DNA-Binding Proteins
  • MAPT protein, human
  • SNCA protein, human
  • TARDBP protein, human
  • alpha-Synuclein
  • tau Proteins